Skip to search formSkip to main contentSkip to account menu

Becaplermin 0.0001 MG/MG Topical Gel [Regranex]

Known as: Regranex 100 MCG per GM Topical Gel, Regranex 0.01 % Topical Gel, BECAPLERMIN 100 ug in 1 g TOPICAL GEL [REGRANEX] 
National Institutes of Health

Related topics

Related topics

13 relations
Acetic AcidBecaplerminCarboxymethylcellulose SodiumLysine Hydrochloride

Broader (1)

Becaplermin Topical Gel [Regranex]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
NorLeu3-Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers.
Significance: Diabetes is a disorder that is well known to delay wound repair resulting in the formation of colonized chronic… 
2011
2011
Les médicaments sont-ils devenus plus dangereux ?
Depuis l'eclatement de l'affaire Mediator® a l'automne dernier, la liste des medicaments retires du marche en raison de leur… 
2010
2010
Becaplermina (Regranex®): contraindicación en pacientes con diagnóstico de cáncer, actual o previo: nota informativa de la AEMPS 2010/03, de 18 de febrero de 2010
La Agencia Espanola de Medicamentos y Productos Sanitarios (AEMPS) informa a los profesionales sanitarios acerca de las… 
2001
2001
The Role of Growth Factors, Cytokines and Proteases in Wound Management
The wound healing process involves a series of cellular and biochemical events that ultimately lead to tissue repair and… 
2000
2000
The costs and effects of Regranex® in the treatment of diabetic feet ulcera (in Dutch)
textabstractDoel. Het verkrijgen van inzicht in de balans tussen kosten en effecten van Regranex, als toevoeging aan de standaard… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)